2025-2026 89th Legislature
HB3717
Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
Committee referrals
March 26, 2025 · House
Public Health
Instrument history
i
This is the complete recorded action history in the current source package. Highlighted entries are marked as significant by the source. A roll-call link appears only when a vote-like action has one unambiguous same-day chamber vote.
-
House Laid on the table subject to call
-
House Companion considered in lieu of CSSB 2308
-
House Postponed 5/12/25 1:00 PM
-
House Laid out as postponed business
-
House Postponed 5/12/25 10:00 AM
-
House Laid out as postponed business
-
House Postponed 5/9/25 9:00 AM
-
House Laid out as postponed business
-
House Postponed 5/7/25 10:00 AM
-
House Read 2nd time
-
House Placed on General State Calendar
-
House Considered in Calendars
-
House Committee report sent to Calendars
-
House Committee report distributed
-
House Comte report filed with Committee Coordinator
-
House Reported favorably w/o amendment(s)
-
House Considered in public hearing
-
House Left pending in committee
-
House Testimony taken/registration(s) recorded in committee
-
House Considered in public hearing
-
House Scheduled for public hearing on . . .
-
House Referred to Public Health
-
House Read first time
-
House Filed